"A NASDAQ listing is an important step for Concordia to achieve that growth because we believe it will broaden our exposure to North American healthcare investors, and could enhance the liquidity of our stock"
In my view, as I stated in the past the liquidity is an issue with only 33 million shares outstanding.
So how do you "enhance the liquidity"?
By doing a blockbuster acquisition in the 1-3 billion amount and finance it with a 10-30 mm share issuance for the US market only.
This listing, - acquisition and financing will most likely be fairly simultaneous. After all what's the point of listing in the US if they aren't issued any shares to trade.
This anticipation should give the stock upward momentum now, to bring it more in line with the various analysts' valuations.
Time will tell, but this is good news indeed.
What's not to like here?